Skip to content

Establishment Labs ESTA Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

AbbVie logo
AbbVieABBV
Solventum logo
SolventumSOLV
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.57B+41.4%

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's treasury stock, shares (in shares)?
Establishment Labs (ESTA) reported treasury stock, shares (in shares) of $408.07K in Q1 2026.
How has Establishment Labs's treasury stock, shares (in shares) changed year-over-year?
Establishment Labs's treasury stock, shares (in shares) decreased by 0.0% year-over-year, from $408.07K to $408.07K.
What is the long-term trend for Establishment Labs's treasury stock, shares (in shares)?
Over 4 years (2021 to 2025), Establishment Labs's treasury stock, shares (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $408.07K to $408.07K.